RELYSTEN Trademark

Trademark Overview

On Friday, March 27, 2026, a trademark application was filed for RELYSTEN with the United States Patent and Trademark Office. The USPTO has given the RELYSTEN trademark a serial number of 99729369. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, March 27, 2026. This trademark is owned by Beam Therapeutics Inc.. The RELYSTEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Sickle Cell Disease
relysten

General Information

Serial Number99729369
Word MarkRELYSTEN
Filing DateFriday, March 27, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, March 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkRELISTEN
Goods and ServicesPharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Sickle Cell Disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 27, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeam Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Trademark Events

Event DateEvent Description
Friday, March 27, 2026NEW APPLICATION ENTERED
Friday, March 27, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 27, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

relysten modification editing gene genome cell nucleobase therapy base human tissue